Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients

2004 ◽  
Author(s):  
Ellen Obermann ◽  
Stefanie Meyer ◽  
Dorothea Hellge ◽  
Dirk Zaak ◽  
Thomas Filbeck ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Cancer Patients ◽  
Chromosome 9 ◽  
Normal Urothelium

DNA cytometry and chromosome 9 aberrations by fluorescence in situ hybridization of irrigation specimens from bladder cancer patients

Urology ◽  
1998 ◽  
Vol 51 (5) ◽  
pp. 58-61 ◽  
Author(s):  
Jay E. Reeder ◽  
Mary J. O’Connell ◽  
Zhihong Yang ◽  
Josephine F. Morreale ◽  
Loretta Collins ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Cancer Patients ◽  
Chromosome 9 ◽  
Dna Cytometry

scholarly journals UroVysion Fluorescence in situ hybridization (UroVysion FISH) assay for detecting Turkish bladder cancer patients in voided urine: A preliminary study

2013 ◽  
Vol 2 ◽  
pp. 156-160
Author(s):  
Yavuz Dodurga ◽  
ÇIğır Biray Avcı ◽  
Sunde Yılmaz ◽  
Oktay NazIı ◽  
Özgür Çoğulu ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Cancer Patients ◽  
Preliminary Study

890: Multiple Fluorescence in Situ Hybridization (FISH) Probes Increase Sensitivity for Detection of Bladder Cancer

2006 ◽  
Vol 175 (4S) ◽  
pp. 287-288 ◽  
Author(s):  
Juliann M. Dziubinski ◽  
Michael F. Sarosdy ◽  
Paul R. Kahn ◽  
Mark D. Ziffer ◽  
William R. Love ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization

A PILOT STUDY OF HER-2/NEU GENE AMPLIFICATION ASSESSED BY FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN GASTRIC CANCER

2014 ◽  
pp. 15-20
Author(s):  
Van Huy Tran ◽  
Thi Minh Thi Ha ◽  
Trung Nghia Van ◽  
Viet Nhan Nguyen ◽  
Phan Tuong Quynh Le ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Cancer Patients ◽  
Gene Amplification ◽  
Cancer Tissue ◽  
Tissue Samples ◽  
Her 2 ◽  
Gastric Cancer Patients

Background: HER-2/neu is a predictive biomarker for treatment of gastric cancer using trastuzumab in combination with chemotherapy. This study aimed to evaluate the status of HER-2/neu gene amplification using fluorescence in situ hybridization (FISH) in gastric cancer. Patients and methods: thirty six gastric cancer patients were assessed HER-2/neu gene amplification by FISH using PathVysionTM HER-2 DNA Probe kit (including HER-2/neu probe and CEP-17 probe) with biopsy and surgical specimens. Results: The HER-2/neu gene amplification was observed in three cases (8.3%), the HER-2/neu gene amplification rate in Lauren’s intestinal-type and diffuse-type were 11.8% and 5.2%, respectively. Conclusion: We applied successfully FISH technique with gastric cancer tissue samples. This technique could be performed as routine test in gastric cancer in order to select patients that benefit from trastuzumab in combination with chemotherapy.

Assessing the Value of Reflex Fluorescence In Situ Hybridization Testing in the Diagnosis of Bladder Cancer When Routine Urine Cytological Examination is Equivocal

2008 ◽  
Vol 179 (4) ◽  
pp. 1296-1301 ◽  
Author(s):  
Benjamin R. Kipp ◽  
Kevin C. Halling ◽  
Michael B. Campion ◽  
Amy J. Wendel ◽  
R. Jeffrey Karnes ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Cytological Examination
Sign in / Sign up

Export Citation Format

Share Document